Biodesix BDSX Cash Flow Statement (2019-2026)

NASDAQ BDSX
$23.40 -0.26 (-1.10%)
At close: Oct 19, 2026 · 4:00 PM EDT
Reported Financials

Biodesix Quarterly Cash Flow Statement

Periods 28 quarters
Latest Jun 2026

Biodesix reported cash from operations of -$1.56M and free cash flow of -$1.76M for the quarter ended Jun 2026, up 76.2% year over year. This cash flow statement covers 28 quarters of results from Sep 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-11.51M-13.28M-15.59M-15.82M-13.70M-20.34M-18.70M-13.36M-10.95M-9.14M-13.61M-10.81M-10.26M-8.25M-11.10M-11.47M-8.72M-3.98M-7.79M-7.27M
Depreciation and DepletionDep. & Depletion
0.30M0.43M0.40M0.40M0.40M0.42M0.30M0.30M0.30M0.45M0.90M0.90M1.00M0.97M0.90M0.90M0.90M0.84M0.90M0.90M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
1.11M1.10M1.01M1.17M2.84M0.03M1.36M1.34M1.26M1.16M1.06M1.02M0.08M0.30M0.31M0.33M0.33M0.33M0.33M0.33M
Depreciation & Amortization (CF)Dep. & Amort.
0.80M0.86M0.91M0.90M0.89M0.90M0.79M0.78M0.78M0.98M1.42M1.41M1.49M1.45M1.44M1.44M1.41M1.39M1.40M1.39M
Share-based CompensationStock Comp.
1.39M1.27M1.35M1.37M1.17M2.08M2.28M1.06M0.95M1.08M2.64M1.22M1.52M1.27M0.97M1.04M1.05M1.08M1.12M0.82M
Asset Writedowns and ImpairmentWritedown
0.40M0.14M0.30M0.07M0.03M0.09M0.09M0.07M0.07M0.10M0.07M0.03M0.01M0.00M0.02M0.01M
Other non-cash itemsOther Non-Cash
-3.12M0.10M0.24M2.95M0.05M4.76M0.14M0.17M1.39M-0.53M0.13M0.25M-0.13M0.38M-0.10M
Change in Working Capital
Change in ReceivablesChange Receivables
-2.50M0.87M0.08M1.68M-0.99M0.74M0.03M-0.61M1.76M3.54M2.34M0.33M-1.86M1.00M-0.90M-0.18M5.22M-3.61M0.49M-0.29M
Change in Accured ExpensesChange Accured Exp.
0.19M1.84M-1.30M0.11M0.55M-0.13M-2.03M3.27M-1.48M0.76M-1.23M0.56M0.62M1.69M-1.94M2.34M0.49M0.97M-2.34M0.77M
Change in Other Operating AssetsOther Assets Change
-1.29M2.16M-0.30M-1.32M3.40M0.61M-0.53M-0.82M-0.42M0.83M0.45M-1.59M0.31M0.04M-0.23M-0.08M0.11M0.58M1.35M-2.40M
Change in Other Operating LiabilitiesOther Liabilities Change
-0.42M0.09M-0.39M-0.51M-0.81M-0.44M-0.07M-0.20M-0.36M-0.63M0.51M0.21M0.24M0.01M0.07M-0.43M1.90M-2.16M-1.11M-0.42M
Other Working Capital ChangesOther WC Changes
0.22M0.21M-0.09M0.81M-4.21M0.14M0.46M0.62M0.06M-1.46M0.06M1.80M-0.08M-0.04M0.30M-0.35M1.80M-2.74M-2.45M1.98M
Other Operating ActivitiesOther Ops.
7.25M5.73M5.35M
Cash from OperationsCash from Ops.
-7.79M-10.20M-13.10M-9.59M-10.33M-11.95M-7.69M0.94M-3.84M-12.28M-15.31M-18.57M-10.67M-4.10M-8.60M-6.57M-8.88M0.78M-10.17M-1.56M
Investing Activities
Capital ExpendituresCapex
0.96M0.53M0.26M0.33M0.78M1.93M7.68M6.42M5.84M2.98M0.23M1.93M0.23M0.84M0.07M0.05M0.05M0.09M0.08M0.20M
Change in Property, Plant and EquipmentChange in PP&E
-0.96M-0.53M-0.26M-0.33M-0.78M-1.93M-7.68M-6.42M-5.84M-2.98M-0.23M-1.93M-0.23M-0.84M-0.07M-0.05M-0.05M-0.09M-0.08M-0.20M
Change in IntangiblesChange Intangibless
0.08M0.11M0.09M0.05M0.04M0.06M0.03M0.06M0.04M0.02M0.04M0.07M0.06M0.05M0.06M0.04M0.02M0.02M0.06M0.06M
Cash from Investing ActivitiesCash from Investing
-1.04M-0.64M-0.35M-0.38M-0.82M-1.99M-7.71M-6.47M-5.88M-3.00M-0.27M-2.00M-0.29M-0.88M-0.14M-0.10M-0.07M-0.10M-0.14M-0.25M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
0.10M15.00M30.00M
Long-Term Debt RepaymentsLT Debt Repayment
0.01M20.00M0.01M3.01M2.01M23.57M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.00M0.01M0.01M0.00M
Non-Current Debt
-0.01M-20.00M0.09M11.99M-2.01M6.43M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M0.00M-0.01M-0.01M0.00M
Net Debt Issuances and RepaymentsNet Debt Issuance
-0.01M-20.00M0.09M11.99M-2.01M6.43M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M0.00M-0.01M-0.01M0.00M
Change in Capital Stock
Common Stock IssuedStock Issued
0.39M16.37M1.88M14.55M2.04M41.69M0.43M0.08M15.30M13.05M0.91M55.00M0.35M0.01M0.31M5.18M2.32M17.57M6.68M
Net Shares Issued and RepurchasedNet Shares Issued
0.39M16.37M1.88M14.55M2.04M41.69M0.43M0.08M15.30M13.05M0.91M55.00M0.35M0.01M0.31M5.18M2.32M17.57M6.68M
Net Equity Issued and RepurchasedNet Equity Issued
0.39M16.37M1.88M14.55M2.04M41.69M0.43M0.08M15.30M13.05M0.91M55.00M0.35M0.01M0.31M5.18M2.32M17.57M6.68M
Other financing activitiesOther financing
0.01M-0.73M-4.66M-4.22M-2.21M-3.62M-2.84M-2.34M-3.38M-1.05M-0.09M-0.10M-0.13M-0.18M-0.21M-0.21M-0.17M-0.26M-0.19M-0.16M
Cash from Financing ActivitiesCash from Financing
0.40M-4.36M-2.83M22.13M-2.27M41.85M-2.42M-2.33M12.15M21.73M0.79M51.30M0.14M-0.18M0.10M9.79M4.82M1.71M16.90M6.24M
Additional items
Change in Cash
-8.44M-15.20M-16.29M12.16M-13.41M27.91M-17.81M-7.87M2.43M6.44M-14.79M30.73M-10.81M-5.16M-8.64M3.13M-4.12M2.38M6.59M4.42M
Ending Cash Balance
48.00M32.80M16.51M28.67M15.26M43.17M25.36M17.50M19.93M26.37M11.58M42.31M31.49M26.33M17.69M20.82M16.69M19.08M25.66M30.08M
Free Cash FlowFCF
-8.75M-10.73M-13.36M-9.92M-11.11M-13.88M-15.36M-5.48M-9.68M-15.27M-15.55M-20.50M-10.90M-4.94M-8.68M-6.62M-8.93M0.69M-10.25M-1.76M
Net Cash FlowNCF
-8.44M-15.20M-16.29M12.16M-13.41M27.91M-17.81M-7.87M2.43M6.44M-14.79M30.73M-10.81M-5.16M-8.64M3.13M-4.12M2.38M6.59M4.42M
Interest Paid
0.56M0.40M0.22M0.12M0.13M0.54M1.03M1.09M1.12M0.75M1.48M1.00M1.97M2.58M1.38M1.56M1.75M1.71M1.62M1.65M

Biodesix Cash Flow Statement API

Pull Biodesix's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=BDSX&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY